UniProtKB/Swiss-Prot P08559: Variant p.Ala136Thr

Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial
Gene: PDHA1
Feedback?

Variant information Variant position:

136 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Alanine (A) to Threonine (T) at position 136 (A136T, p.Ala136Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and hydrophobic (A) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Found in a patient with moderate developmental delay, mild dysmorphism and mildly elevated serum lactate; uncertain significance. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs138727886 [ dbSNP | Ensembl ]

Sequence information Variant position:

136 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

390 The length of the canonical sequence.
Location on the sequence:

TAYRAHGFTFTRGLSVREIL A ELTGRKGGCAKGKGGSMHMY The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TAYRAHGFTFTRGLSVREILAELTGRKGGCAKGKGGSMHMY

Chimpanzee                    TAYRAHGFTFTRGLSVREILAELTGRKGGCAKGKGGSMHMY

Mouse                         TAYRAHGFTFTRGLPVRAILAELTGRRGGCAKGKGGSMHMY

Rat                           TAYRAHGFTFNRGHAVRAILAELTGRRGGCAKGKGGSMHMY

Bovine                        TAYRAHGFTFTRGLSVREILAELTGRRGGCAKGKGGSMHMY

Caenorhabditis elegans        TAYRCHGWTWLLGATVTEVLAELTGRVAGNVHGKGGSMHMY

Slime mold                    TAYRDHTYMLSRGATPEEIFAELLMKETGCSKGKGGSMHMF

Baker's yeast                 TSYRCHGFTFMRGASVKAVLAELMGRRAGVSYGKGGSMHLY

Fission yeast                 TSYRCHGFAYTRGLSIRSIIGELMGRQCGASKGKGGSMHIF

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	30 – 390	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial
Binding site	118 – 118
Binding site	118 – 118
Binding site	119 – 119
Binding site	119 – 119
Helix	131 – 138

Literature citations
Diagnostic exome sequencing in persons with severe intellectual disability.
de Ligt J.; Willemsen M.H.; van Bon B.W.; Kleefstra T.; Yntema H.G.; Kroes T.; Vulto-van Silfhout A.T.; Koolen D.A.; de Vries P.; Gilissen C.; del Rosario M.; Hoischen A.; Scheffer H.; de Vries B.B.; Brunner H.G.; Veltman J.A.; Vissers L.E.;
N. Engl. J. Med. 367:1921-1929(2012)
Cited for: VARIANT THR-136;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.